FDA.reportPublic FDA data

edaravone 1050 MG per 50 ML Oral Suspension

RxCUI
2602117
RxNorm name
edaravone 1050 MG per 50 ML Oral Suspension
Display name
edaravone 1050 MG per 50 ML Oral Suspension
Full name
edaravone 1050 MG per 50 ML Oral Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RADICAVA ORSEDARAVONEShionogi Inc.0ce2c1c4-2a40-485c-b7cb-96a9b85d9d112026-05-05Warnings, Adverse reactionsExact identifier
rxcui: 2602117

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0ce2c1c4-2a40-485c-b7cb-96a9b85d9d11edaravone 21 MG/mL Oral Suspension [PSN] · edaravone 21 MG/ML Oral Suspension [SCD] · edaravone 1050 MG per 50 ML Oral Suspension [SY] · edaravone 735 MG per 35 ML Oral Suspension [SY]429These highlights do not include all the information needed to use RADICAVA or RADICAVA ORS safely and effectively. See full prescribing information for RADICAVA or RADICAVA ORS. RADICAVA ® (edaravone) injection, for intravenous use RADICAVA ORS ® (edaravone) oral suspension Initial U.S. Approval: 201720260505